Molecular Mosaics: Unveiling Heterogeneity in Synchronous Colorectal Cancers
Cancer Research and Treatment · 2026
DOI: 10.4143/crt.2024.947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2026. Verfasst von Hyun Gu Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colon and Rectal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Neoplasms, Multiple Primary, Genetic Heterogeneity. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Asan Institute for Life Sciences, Asan Medical Center.
Abstract (Originalsprache)
Purpose
Molecular characteristics of synchronous colorectal cancers (SCRCs) remain incompletely elucidated, despite their importance in targeted therapy selection. We compared the molecular characteristics and somatic mutations between SCRCs.Materials and Methods This retrospective study (2012-2014) included 98 consecutive patients with surgically resected SCRCs. Molecular characteristics, including microsatellite instability (MSI) and tumor-infiltrating lymphocytes (TILs), were analyzed for all cancer lesions. The intertumoral heterogeneity of SCRCs was evaluated using whole-exome sequencing (WES) for 18 cancers from nine patients with at least one MSI-high (MSI-H) tumor.
Results
Twelve patients had at least one MSI-H tumor; five showed discordant MSI status. Mucinous adenocarcinoma frequency and TIL density were higher in patients with at least one MSI-H tumor than in those with only microsatellite-stable tumors. WES revealed that, except one patient (6.5%), most synchronous cancers shared few variants in each patient (0.09%-0.36%). The concordance rates for BRAF, KRAS, NRAS, and PIK3CA, in synchronous cancers from each patient were 66.7%, 66.7%, 66.7%, and 55.6%, respectively.
Conclusion
Although synchronous cancers shared a mutated gene, the mutation subtypes differed. SCRCs exhibited 5.1% MSI status discordance rate and a high discordance rate in somatic mutational variants. As intertumoral heterogeneity may affect the targeted therapy response, molecular analysis of all tumors is recommended for patients with SCRCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Colon and Rectal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Pathology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
- Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
- Department of Pathology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Asan Institute for Life Sciences, Asan Medical Center
Zitieren
APA
Lee, H. G., Kim, Y., Kim, M. J., Kim, Y. W., Jun, S. Y., Kim, D., Park, I. J., & Hong, S. M. (2026). Molecular Mosaics: Unveiling Heterogeneity in Synchronous Colorectal Cancers. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.947
Vancouver
Lee HG, Kim Y, Kim MJ, Kim YW, Jun SY, Kim D, et al. Molecular Mosaics: Unveiling Heterogeneity in Synchronous Colorectal Cancers. Cancer Research and Treatment. 2026. doi:10.4143/crt.2024.947
BibTeX
@article{Lee2026,
author = {Lee, Hyun Gu and Kim, Yeseul and Kim, Mi-Ju and Kim, Yeon Wook and Jun, Sun-Young and Kim, Deokhoon and Park, In Ja and Hong, Seung-Mo},
title = {Molecular Mosaics: Unveiling Heterogeneity in Synchronous Colorectal Cancers},
journal = {Cancer Research and Treatment},
year = {2026},
doi = {10.4143/crt.2024.947}
}
EUVIMED